bioRxiv · 10.1101/2024.01.02.573710
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA
Abstract
Analysis of DNA methylation in cell-free DNA (cfDNA) reveals clinically relevant biomarkers but requires specialized protocols and sufficient input material that limits its applicability. Millions of cfDNA samples have been profiled by genomic sequencing. To maximize the gene regulation information from the existing dataset, we developed FinaleMe, a non-homogeneous Hidden Markov Model (HMM), to predict DNA methylation of cfDNA and, therefore, tissues-of-origin directly from plasma whole-genome sequencing (WGS). We validated the performance with 80 pairs of deep and shallow-coverage WGS and whole-genome bisulfite sequencing (WGBS) data.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Liu, Y., Reed, S. C., Lo, C., Choudhury, A. D., Parsons, H. A., Stover, D. G., Ha, G., Gydush, G., Rhoades, J., Rotem, D., Freeman, S., Katz, D., Bandaru, R., Zheng, H., Fu, H., Adalsteinsson, V. A., Kellis, M.. 2024-01-02. FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA. https://doi.org/10.1101/2024.01.02.573710
Cite the original work for its findings. Save a collection to share your selection of sources.